BL Pharmtech Corp. (KOSDAQ: 065170)
South Korea
· Delayed Price · Currency is KRW
2,340.00
+450.00 (23.81%)
Dec 11, 2024, 9:00 AM KST
BL Pharmtech Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | - | 24,525 | 22,523 | 84,440 | 65,691 | 58,869 | Upgrade
|
Other Revenue | 0 | - | - | -0 | - | - | Upgrade
|
Revenue | 11,943 | 24,525 | 22,523 | 84,440 | 65,691 | 58,869 | Upgrade
|
Revenue Growth (YoY) | - | 8.89% | -73.33% | 28.54% | 11.59% | -32.86% | Upgrade
|
Cost of Revenue | 3,178 | 10,964 | 9,801 | 63,367 | 45,331 | 36,449 | Upgrade
|
Gross Profit | 8,765 | 13,561 | 12,722 | 21,073 | 20,360 | 22,421 | Upgrade
|
Selling, General & Admin | 11,137 | 19,811 | 16,825 | 24,014 | 21,940 | 24,832 | Upgrade
|
Operating Expenses | 12,175 | 20,680 | 17,510 | 24,668 | 22,423 | 30,508 | Upgrade
|
Operating Income | -3,410 | -7,119 | -4,789 | -3,595 | -2,063 | -8,087 | Upgrade
|
Interest Expense | -919.52 | -1,573 | -2,206 | -2,591 | -2,138 | -1,113 | Upgrade
|
Interest & Investment Income | 265.3 | 51.42 | 131.12 | 103 | 196.87 | 565.85 | Upgrade
|
Earnings From Equity Investments | -469.42 | -469.42 | -358.97 | -51.29 | 16.06 | - | Upgrade
|
Currency Exchange Gain (Loss) | -6.8 | 9.56 | 64.6 | -374.37 | 252.97 | 75.34 | Upgrade
|
Other Non Operating Income (Expenses) | -2,982 | -2,854 | -2,079 | -1,012 | 2,943 | -21,208 | Upgrade
|
EBT Excluding Unusual Items | -7,522 | -11,955 | -9,237 | -7,521 | -792.63 | -29,767 | Upgrade
|
Gain (Loss) on Sale of Investments | -17.02 | - | 283.8 | 67.12 | -5,858 | -49.09 | Upgrade
|
Gain (Loss) on Sale of Assets | 80.69 | 53.01 | - | 3,084 | 162.45 | 192.15 | Upgrade
|
Asset Writedown | -975.77 | -2,900 | -5,151 | -16,238 | -13,724 | -614.11 | Upgrade
|
Other Unusual Items | 259.02 | 944.78 | 31.04 | 38.48 | - | 1,373 | Upgrade
|
Pretax Income | -8,175 | -13,856 | -14,073 | -20,570 | -14,357 | -16,597 | Upgrade
|
Income Tax Expense | 38.6 | -46.23 | 363.26 | -462.69 | 2,230 | 856.08 | Upgrade
|
Earnings From Continuing Operations | -8,214 | -13,810 | -14,437 | -20,107 | -16,587 | -17,453 | Upgrade
|
Earnings From Discontinued Operations | 12,435 | 13,952 | 787.1 | - | - | - | Upgrade
|
Net Income to Company | 4,221 | 141.62 | -13,649 | -20,107 | -16,587 | -17,453 | Upgrade
|
Minority Interest in Earnings | 339.24 | -290.47 | -253.65 | -104.49 | -1,360 | 5,634 | Upgrade
|
Net Income | 4,560 | -148.85 | -13,903 | -20,211 | -17,947 | -11,820 | Upgrade
|
Net Income to Common | 4,560 | -148.85 | -13,903 | -20,211 | -17,947 | -11,820 | Upgrade
|
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 7 | 6 | Upgrade
|
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 7 | 6 | Upgrade
|
Shares Change (YoY) | 0.78% | - | 1.33% | 18.44% | 19.95% | 9.75% | Upgrade
|
EPS (Basic) | 510.56 | -16.73 | -1562.69 | -2301.97 | -2421.10 | -1912.53 | Upgrade
|
EPS (Diluted) | 510.56 | -16.73 | -1562.69 | -2301.97 | -2421.10 | -1912.53 | Upgrade
|
Free Cash Flow | -4,441 | 7,680 | -12,706 | 2,510 | -11,822 | -19,839 | Upgrade
|
Free Cash Flow Per Share | -497.29 | 863.20 | -1428.13 | 285.84 | -1594.79 | -3210.19 | Upgrade
|
Gross Margin | 73.39% | 55.29% | 56.48% | 24.96% | 30.99% | 38.09% | Upgrade
|
Operating Margin | -28.55% | -29.03% | -21.26% | -4.26% | -3.14% | -13.74% | Upgrade
|
Profit Margin | 38.18% | -0.61% | -61.73% | -23.94% | -27.32% | -20.08% | Upgrade
|
Free Cash Flow Margin | -37.19% | 31.31% | -56.41% | 2.97% | -18.00% | -33.70% | Upgrade
|
EBITDA | -2,597 | -6,271 | -3,888 | -146.75 | 469.45 | -6,497 | Upgrade
|
EBITDA Margin | -21.74% | -25.57% | -17.26% | -0.17% | 0.71% | -11.04% | Upgrade
|
D&A For EBITDA | 813.18 | 848.1 | 900.55 | 3,448 | 2,533 | 1,590 | Upgrade
|
EBIT | -3,410 | -7,119 | -4,789 | -3,595 | -2,063 | -8,087 | Upgrade
|
EBIT Margin | -28.55% | -29.03% | -21.26% | -4.26% | -3.14% | -13.74% | Upgrade
|
Advertising Expenses | - | 3,675 | 2,206 | 2,535 | 1,361 | 992.28 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.